Cynthia M Chweya, Rahul Alapati, Adip G Bhargav, Robert Wright, Antonio Bon Nieves, Kiara Holtkamp, David Rouse, Christopher Larsen
{"title":"Predictors of Hypoglossal Nerve Stimulator Usage: A Growth Curve Analysis Study.","authors":"Cynthia M Chweya, Rahul Alapati, Adip G Bhargav, Robert Wright, Antonio Bon Nieves, Kiara Holtkamp, David Rouse, Christopher Larsen","doi":"10.1002/ohn.1219","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study is to evaluate the long-term usage of the hypoglossal nerve stimulator and identify predictors of usage over time.</p><p><strong>Study design: </strong>Retrospective chart review.</p><p><strong>Setting: </strong>Tertiary academic medical center and database.</p><p><strong>Methods: </strong>Single institution retrospective chart review was merged with Inspire SleepSync device usage data. Growth curve modeling was performed with a linear mixed-effects model to evaluate usage hours over time. A logistic regression analysis was also performed to assess the relationship between early adherence and adherence at 1 and 2 years.</p><p><strong>Results: </strong>A total of 352 patients were included in the study. Seventy percent were male and the mean age was 64 ± 12 years. Adherence at 6 months was significantly predictive of adherence at 12 (odds ratio [OR] 9.42, CI 3.23-28.76, P < .001) and 24 (OR 3.03, CI 0.96-9.05, P = .049) months. Older age (estimate = 0.019, SE 0.006, P = .002) and greater days of use per biweekly period (estimate = 0.142, SE 0.004, P < .001) were positive predictors of usage. Insomnia (estimate = -0.386, SE 0.128, P = .003) and higher device mean voltage amplitude (estimate = -0.348, SE 0.020, P < .001) were negative predictors.</p><p><strong>Conclusion: </strong>Time since activation does not appear to have an impact on hypoglossal nerve stimulator therapy usage. Insomnia and higher device voltage were associated with a statistically significant negative trend in therapy usage, whereas older age and greater number of days used may be predictive of higher therapy usage. Identifying predictors of usage will enable identification of at-risk patients and allow for early implementation of targeted interventions to improve patient adherence and optimize long-term health outcomes.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otolaryngology- Head and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ohn.1219","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The purpose of this study is to evaluate the long-term usage of the hypoglossal nerve stimulator and identify predictors of usage over time.
Study design: Retrospective chart review.
Setting: Tertiary academic medical center and database.
Methods: Single institution retrospective chart review was merged with Inspire SleepSync device usage data. Growth curve modeling was performed with a linear mixed-effects model to evaluate usage hours over time. A logistic regression analysis was also performed to assess the relationship between early adherence and adherence at 1 and 2 years.
Results: A total of 352 patients were included in the study. Seventy percent were male and the mean age was 64 ± 12 years. Adherence at 6 months was significantly predictive of adherence at 12 (odds ratio [OR] 9.42, CI 3.23-28.76, P < .001) and 24 (OR 3.03, CI 0.96-9.05, P = .049) months. Older age (estimate = 0.019, SE 0.006, P = .002) and greater days of use per biweekly period (estimate = 0.142, SE 0.004, P < .001) were positive predictors of usage. Insomnia (estimate = -0.386, SE 0.128, P = .003) and higher device mean voltage amplitude (estimate = -0.348, SE 0.020, P < .001) were negative predictors.
Conclusion: Time since activation does not appear to have an impact on hypoglossal nerve stimulator therapy usage. Insomnia and higher device voltage were associated with a statistically significant negative trend in therapy usage, whereas older age and greater number of days used may be predictive of higher therapy usage. Identifying predictors of usage will enable identification of at-risk patients and allow for early implementation of targeted interventions to improve patient adherence and optimize long-term health outcomes.
期刊介绍:
Otolaryngology–Head and Neck Surgery (OTO-HNS) is the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation. The mission of Otolaryngology–Head and Neck Surgery is to publish contemporary, ethical, clinically relevant information in otolaryngology, head and neck surgery (ear, nose, throat, head, and neck disorders) that can be used by otolaryngologists, clinicians, scientists, and specialists to improve patient care and public health.